Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Review of angiogenesis in hepatocellular carcinoma
Jun Muto, Ken Shirabe, K Sugimachi, et al.
Hepatology Research (2014) Vol. 45, Iss. 1, pp. 1-9
Closed Access | Times Cited: 86

Showing 26-50 of 86 citing articles:

AISF position paper on liver disease and pregnancy
Filomena Morisco, Raffaele Bruno, Elisabetta Bugianesi, et al.
Digestive and Liver Disease (2015) Vol. 48, Iss. 2, pp. 120-137
Open Access | Times Cited: 37
Cross-talk mechanism between endothelial cells and hepatocellular carcinoma cells via growth factors and integrin pathway promotes tumor angiogenesis and cell migration
Feng Tang, Hongchi Yu, Qing Xia, et al.
Oncotarget (2017) Vol. 8, Iss. 41, pp. 69577-69593
Open Access | Times Cited: 36
Candesartan attenuates angiogenesis in hepatocellular carcinoma via downregulating AT1R/VEGF pathway
Fangtian Fan, Chao Tian, Tao Li, et al.
Biomedicine & Pharmacotherapy (2016) Vol. 83, pp. 704-711
Closed Access | Times Cited: 32
Phase I Study of Sorafenib and Vorinostat in Advanced Hepatocellular Carcinoma
Sarah Gordon, William P. McGuire, Danielle Shafer, et al.
American Journal of Clinical Oncology (2019) Vol. 42, Iss. 8, pp. 649-654
Closed Access | Times Cited: 30
HIF-1α and VEGF as prognostic biomarkers in hepatocellular carcinoma patients treated with transarterial chemoembolization
Elisa Pinto, Filippo Pelizzaro, Romilda Cardin, et al.
Digestive and Liver Disease (2023) Vol. 56, Iss. 5, pp. 872-879
Open Access | Times Cited: 10
Exosomes delivering miR-129-5p combined with sorafenib ameliorate hepatocellular carcinoma progression via the KCTD1/HIF-1α/VEGF pathway
Xinyu Zhu, Zhiwei Li, Li Chen, et al.
Cellular Oncology (2025)
Open Access
AGK enhances angiogenesis and inhibits apoptosis via activation of the NF-κB signaling pathway in hepatocellular carcinoma
Yanmei Cui, Chuyong Lin, Zhiqiang Wu, et al.
Oncotarget (2014) Vol. 5, Iss. 23, pp. 12057-12069
Open Access | Times Cited: 33
Overexpression of AGGF1 is correlated with angiogenesis and poor prognosis of hepatocellular carcinoma
Wei Wang, Guangyao Li, Jianyu Zhu, et al.
Medical Oncology (2015) Vol. 32, Iss. 4
Closed Access | Times Cited: 31
Inhibition of VEGF165/VEGFR2-dependent signaling by LECT2 suppresses hepatocellular carcinoma angiogenesis
Chi-Kuan Chen, Wen-Hsuan Yu, Tsu‐Yao Cheng, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 28
Intravoxel incoherent motion diffusion‐weighted imaging for characterizing focal hepatic lesions: Correlation with lesion enhancement
In Young Choi, Seung Soo Lee, Yu Sub Sung, et al.
Journal of Magnetic Resonance Imaging (2016) Vol. 45, Iss. 6, pp. 1589-1598
Open Access | Times Cited: 28
Perivascular Tumor-Infiltrating Leukocyte Scoring for Prognosis of Resected Hepatocellular Carcinoma Patients
Markus Bo Schoenberg, Jingcheng Hao, Julian Nikolaus Bucher, et al.
Cancers (2018) Vol. 10, Iss. 10, pp. 389-389
Open Access | Times Cited: 28
Benzimidazole–dioxoisoindoline conjugates as dual VEGFR-2 and FGFR-1 inhibitors: design, synthesis, biological investigation, molecular docking studies and ADME predictions
Heba T. Abdel‐Mohsen, Amira M. Nageeb
RSC Advances (2024) Vol. 14, Iss. 39, pp. 28889-28903
Open Access | Times Cited: 3
The Role of Endoglin in Hepatocellular Carcinoma
Kuo‐Shyang Jeng, I‐Shyan Sheen, Shu-Sheng Lin, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 6, pp. 3208-3208
Open Access | Times Cited: 18
LECT2: A pleiotropic and promising hepatokine, from bench to bedside
Yuan Xie, Kai‐Wei Fan, Shi‐Xing Guan, et al.
Journal of Cellular and Molecular Medicine (2022) Vol. 26, Iss. 13, pp. 3598-3607
Open Access | Times Cited: 14
Can PSMA-Targeting Radiopharmaceuticals Be Useful for Detecting Hepatocellular Carcinoma Using Positron Emission Tomography? An Updated Systematic Review and Meta-Analysis
Alessio Rizzo, Manuela Racca, Domenico Albano, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 11, pp. 1368-1368
Open Access | Times Cited: 14
Dahuang Zhechong pill attenuates hepatic sinusoidal capillarization in liver cirrhosis and hepatocellular carcinoma rat model via the MK/integrin signaling pathway
Chuankui Fu, Yiheng Zhang, Wen jie Xi, et al.
Journal of Ethnopharmacology (2023) Vol. 308, pp. 116191-116191
Closed Access | Times Cited: 8
New 2,4‐disubstituted‐2‐thiopyrimidines as VEGFR‐2 inhibitors: Design, synthesis, and biological evaluation
Heba T. Abdel‐Mohsen, Adel S. Girgis, Abeer E. Mahmoud, et al.
Archiv der Pharmazie (2019) Vol. 352, Iss. 11
Closed Access | Times Cited: 22
Remission of Psoriasis in a Patient with Hepatocellular Carcinoma Treated with Sorafenib.
Efstathios Antoniou, Ioannis Koutsounas, Christos Damaskos, et al.
PubMed (2016) Vol. 30, Iss. 5, pp. 677-80
Closed Access | Times Cited: 21
Roles and Signaling Pathways of Des-γ-Carboxyprothrombin in the Progression of Hepatocellular Carcinoma
Shu‐Xiang Cui, Xinfeng Yu, Xian‐Jun Qu
Cancer Investigation (2016) Vol. 34, Iss. 9, pp. 459-464
Closed Access | Times Cited: 18
Extract Derived from Cedrus atlantica Acts as an Antitumor Agent on Hepatocellular Carcinoma Growth In Vitro and In Vivo
Xiao‐Fan Huang, Kai‐Fu Chang, Shan‐Chih Lee, et al.
Molecules (2020) Vol. 25, Iss. 20, pp. 4608-4608
Open Access | Times Cited: 18
Dynamic 18F-FDG PET imaging of liver lesions: evaluation of a two-tissue compartment model with dual blood input function
Jingnan Wang, Yunwen Shao, Bowei Liu, et al.
BMC Medical Imaging (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 15
Hepatic epithelioid hemangioendothelioma—a single-institution experience with 51 cases
Lei Feng, Manjie Li, Zhuo Huang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 6
Overexpression of c-kit(CD117), relevant with microvessel density, is an independent survival prognostic factor for patients with HBV-related hepatocellular carcinoma
Weiwei Yan, Zhenyu Zhu, Fei Pan, et al.
OncoTargets and Therapy (2018) Vol. Volume 11, pp. 1285-1292
Open Access | Times Cited: 17
Chemotherapeutic perfusion of portal vein after tumor thrombectomy and hepatectomy benefits patients with advanced hepatocellular carcinoma: A propensity score‐matched survival analysis
Yang Gao, Pengxiang Wang, Jianwen Cheng, et al.
Cancer Medicine (2019) Vol. 8, Iss. 16, pp. 6933-6944
Open Access | Times Cited: 17
In vitro and in vivo study of hydralazine, a potential anti-angiogenic agent
Quanwei Zhang, Zhexuan Lin, Xiu-Kai Yin, et al.
European Journal of Pharmacology (2016) Vol. 779, pp. 138-146
Closed Access | Times Cited: 16

Scroll to top